Provided by Tiger Fintech (Singapore) Pte. Ltd.

Qualigen Therapeutics, Inc.

3.85
+0.04001.05%
Post-market: 3.55-0.3000-7.79%18:50 EDT
Volume:304.92K
Turnover:1.24M
Market Cap:2.84M
PE:-0.09
High:4.40
Open:3.86
Low:3.55
Close:3.81
Loading ...
Aug 22, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Aug 15, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 13, 2024

Correspondence

Form CORRESP - Correspondence
Aug 13, 2024

Correspondence

Form CORRESP - Correspondence
Aug 13, 2024

Correspondence

Form CORRESP - Correspondence
Aug 13, 2024

Correspondence

Form CORRESP - Correspondence
Aug 10, 2024

Correspondence

Form CORRESP - Correspondence
Aug 09, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Aug 07, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Aug 05, 2024

Major Issues Report

Form 8-K - Current report
Jul 18, 2024

Major Issues Report

Form 8-K - Current report
Jul 15, 2024

Major Issues Report

Form 8-K - Current report
Jul 15, 2024

Major Issues Report

Form 8-K - Current report
Jul 11, 2024

Major Issues Report

Form 8-K - Current report
Jul 02, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 30, 2024

Major Issues Report

Form 8-K - Current report
May 06, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Apr 16, 2024

Major Issues Report

Form 8-K - Current report
Apr 08, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 28, 2024

Major Issues Report

Form 8-K - Current report